Cargando…
The Prostate Cancer Cells Resistant to Docetaxel as in vitro Model for Discovering MicroRNAs Predictive of the Onset of Docetaxel Resistance
On the grounds that miRNAs present in the blood of prostate cancer (PCa) patients are released in the growth medium by PCa cells, it is conceivable that PCa cells resistant to docetaxel (DCT) (DCT(R)) will release miRNAs that may be found in PCa patients under DCT therapy if resistant PCa cells appe...
Autores principales: | Bascetta, Lorenzo, Oliviero, Arianna, D’Aurizio, Romina, Evangelista, Monica, Mercatanti, Alberto, Pellegrini, Marco, Marrocolo, Francesca, Bracarda, Sergio, Rizzo, Milena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536002/ https://www.ncbi.nlm.nih.gov/pubmed/28703747 http://dx.doi.org/10.3390/ijms18071512 |
Ejemplares similares
-
The miR-28-5p Targetome Discovery Identified SREBF2 as One of the Mediators of the miR-28-5p Tumor Suppressor Activity in Prostate Cancer Cells
por: Fazio, Sofia, et al.
Publicado: (2020) -
Discovering the miR-26a-5p Targetome in Prostate Cancer Cells
por: Rizzo, Milena, et al.
Publicado: (2017) -
Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel
por: Kopczyńska, Ewa
Publicado: (2016) -
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
por: Omoboyede, Victor, et al.
Publicado: (2023) -
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
por: Lin, H-M, et al.
Publicado: (2014)